1. Home
  2. FMX vs ZTS Comparison

FMX vs ZTS Comparison

Compare FMX & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fomento Economico Mexicano S.A.B. de C.V.

FMX

Fomento Economico Mexicano S.A.B. de C.V.

N/A

Current Price

$131.85

Market Cap

41.4B

ML Signal

N/A

Logo Zoetis Inc.

ZTS

Zoetis Inc.

N/A

Current Price

$83.62

Market Cap

33.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FMX
ZTS
Founded
1890
1952
Country
Mexico
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.4B
33.5B
IPO Year
1998
2012

Fundamental Metrics

Financial Performance
Metric
FMX
ZTS
Price
$131.85
$83.62
Analyst Decision
Buy
Hold
Analyst Count
15
16
Target Price
★ $135.93
$89.69
AVG Volume (30 Days)
793.7K
★ 4.1M
Earning Date
10-28-2026
11-05-2026
Dividend Yield
★ 5.12%
2.56%
EPS Growth
N/A
★ 10.05
EPS
N/A
★ 4.51
Revenue
N/A
★ $9,467,000,000.00
Revenue This Year
$7.78
N/A
Revenue Next Year
$7.89
$0.54
P/E Ratio
$40.94
★ $18.38
Revenue Growth
N/A
★ 2.28
52 Week Low
$92.55
$68.92
52 Week High
$141.47
$132.49

Technical Indicators

Market Signals
Indicator
FMX
ZTS
Relative Strength Index (RSI) 64.47 58.55
Support Level $121.26 $71.78
Resistance Level $134.52 $89.29
Average True Range (ATR) 2.95 2.63
MACD 0.31 -0.08
Stochastic Oscillator 82.87 54.49

Price Performance

Historical Comparison
FMX
ZTS

About FMX Fomento Economico Mexicano S.A.B. de C.V.

Mexico-based Femsa is a beverage and retail conglomerate in Central and South America. The holding company owns controlling stakes in bottler Coca-Cola Femsa (47% economic stake, 56% voting rights), in addition to operating 100%-owned retail assets, including convenience stores under the Oxxo banner, drugstores, and gas stations. The firm divested its 15% stake in Heineken and its distribution business in 2023. Coca-Cola Femsa and the Oxxo chain made up over 70% of total company revenue and over 90% of profits in 2025.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 30% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 70% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: